HOPE-Neuron opens Republic crowdfunding round for first human ALS trial
HOPE-Neuron Therapeutx has opened a Regulation Crowdfunding round on Republic to finance the first human trial of its SELtx ALS treatment. The company says proceeds will support device manufacturing, IRB review, and initial patient dosing. It expects human test results within 12 months of funding.